Status:
RECRUITING
Small Vessel Diseases: Ultra-realistic Microstructure Computational Model to Refine Individual Treatment
Lead Sponsor:
University Hospital, Tours
Conditions:
Small Vessel Disease
Eligibility:
All Genders
82-100 years
Phase:
NA
Brief Summary
Small vessel disease (SVD) accounts for 25% of strokes and is the second most common cause of dementia after Alzheimer's disease. Unlike other causes of stroke, SVD manifests itself years before the s...
Eligibility Criteria
Inclusion
- Prior Enrollement in Tours body donation program Age ≥ 82 years Able to remain supine in the MR scanner for acquisition (duration 60-minutes) Affiliation to social security Informed and written consent
Exclusion
- Contraindications to body donation, especially infectious disease (VIH, HBV…) Contraindications to MRI
Key Trial Info
Start Date :
March 26 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06159140
Start Date
March 26 2024
End Date
March 1 2026
Last Update
May 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UHT of Tours
Tours, France